We are live on
!
Find out more
DAM
DLD Asset Management Portfolio holdings
AUM
$1.51B
Turnover
51.11%
1-Year Est. Return
5.32%
This Fund
S&P 500
This Quarter
Est. Return
+2.44%
1 Year Est. Return
+5.32%
3 Year Est. Return
+10.27%
5 Year Est. Return
+32.59%
10 Year Est. Return
–
AUM
$1.51B
AUM Growth
+$414M
(+38%)
Cap. Flow
-$406M
Cap. Flow
% of AUM
-26.85%
Top 10 Holdings %
Top 10 Hldgs %
44.89%
Holding
542
New
183
Increased
53
Reduced
33
Closed
94
Avg Time Held Equity + Options
0.3
years
Top 10 Avg Time Held Equity + Options
0.4
years
Top 20 Avg Time Held Equity + Options
0.4
years
Avg Time Held Equity only
0.3
years
Top 10 Avg Time Held Equity only
0.4
years
Top 20 Avg Time Held Equity only
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amkor Technology
AMKR
|
+$9.98M |
| 2 |
Aurora
AUR
|
+$9.24M |
| 3 |
Digital Realty Trust
DLR
|
+$6.7M |
| 4 |
Nouveau Monde Graphite
NMG
|
+$6.04M |
| 5 |
SILA
Sila Realty Trust
SILA
|
+$5.34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medline Inc
MDLN
|
+$9.79M |
| 2 |
StandardAero Inc
SARO
|
+$7.75M |
| 3 |
CEPT
Cantor Equity Partners II
CEPT
|
+$7.19M |
| 4 |
MACOM Technology Solutions
MTSI
|
+$5.11M |
| 5 |
D. Boral Acquisition I Corp
DBCA
|
+$4.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 77.92% |
| 2 | Financials | 15.61% |
| 3 | Technology | 1.32% |
| 4 | Real Estate | 1.26% |
| 5 | Industrials | 1.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
Paloma Acquisition Corp I
PALO
$211M
| $991K | 0.07% |
+100,000
| New | +$989K |
2026 Q2
0 quarters
|
|
202
ClearThink 1 Acquisition Corp
CTAA
$170M
| $991K | 0.07% |
+100,000
| New | +$988K |
2026 Q2
0 quarters
|
|
203
PUT
Compass Pathways
CMPS
$1.61B
| $991K | 0.07% |
70,000
+1,800
| +3% | +$18.3K |
2025 Q3
3 quarters
|
|
204
Illumination Acquisition Corp I
ILLU
| $990K | 0.07% |
+100,000
| New | +$989K |
2026 Q2
0 quarters
|
|
|
APUR
205
Aperture AC
APUR
| $990K | 0.07% |
+100,000
| New | +$990K |
2026 Q2
0 quarters
|
|
206
PUT
Karyopharm Therapeutics
KPTI
$7.96M
| $990K | 0.07% |
+101,500
| New | +$880K |
2026 Q2
0 quarters
|
|
207
SUMA Acquisition Corp
SUMA
$234M
| $989K | 0.07% |
+100,000
| New | +$985K |
2026 Q2
0 quarters
|
|
208
RRE Ventures Acquisition Corp
RREV
| $987K | 0.07% |
+100,000
| New | +$988K |
2026 Q2
0 quarters
|
|
209
CALL
Novo Nordisk
NVO
$173B
| $959K | 0.06% |
+20,000
| New | +$859K |
2026 Q2
0 quarters
|
|
|
210
PUT
Novo Nordisk
NVO
$173B
| $959K | 0.06% |
+20,000
| New | +$859K |
2026 Q2
0 quarters
|
|
211
Xerox Holdings Corp Warrants
XRXDW
$16.7M
| $872K | 0.06% |
3,170,000
+763,383
| +32% | +$208K |
2026 Q1
1 quarter
|
|
212
CALL
Cytokinetics
CYTK
$8.89B
| $852K | 0.06% |
10,000
+2,500
| +33% | +$180K |
2026 Q1
1 quarter
|
|
213
FACT II Acquisition Corp
FACT
$261M
| $817K | 0.05% |
+76,830
| New | +$815K |
2026 Q2
0 quarters
|
|
214
CALL
Titan Mining Corp
TII
$201M
| $789K | 0.05% |
+357,000
| New | +$889K |
2026 Q2
0 quarters
|
|
|
215
CALL
Karyopharm Therapeutics
KPTI
$7.96M
| $781K | 0.05% |
+80,100
| New | +$695K |
2026 Q2
0 quarters
|
|
216
Cantor Equity Partners VI
CEPS
$148M
| $764K | 0.05% |
73,676
+10,565
| +17% | +$108K |
2026 Q1
1 quarter
|
|
217
Inflection Point Acquisition Corp. VII Class A Ordinary Shares
IPXG
$317M
| $761K | 0.05% |
75,000
| – | – |
2026 Q1
1 quarter
|
|
218
Safeguard Acquisition Corp
SAC
$317M
| $758K | 0.05% |
75,300
| – | – |
2026 Q1
1 quarter
|
|
219
Meshflow Acquisition Corp
MESH
$434M
| $751K | 0.05% |
75,000
| – | – |
2026 Q1
1 quarter
|
|
220
Proem Acquisition Corp I
PAAC
$177M
| $746K | 0.05% |
+75,000
| New | +$743K |
2026 Q2
0 quarters
|
|
221
CALL
Kopin
KOPN
$688M
| $731K | 0.05% |
+163,600
| New | +$713K |
2026 Q2
0 quarters
|
|
222
PUT
Jazz Pharmaceuticals
JAZZ
$13.9B
| $723K | 0.05% |
+3,000
| New | +$657K |
2026 Q2
0 quarters
|
|
223
PUT
Definium Therapeutics
DFTX
$4.6B
| $710K | 0.05% |
+15,100
| New | +$373K |
2026 Q2
0 quarters
|
|
224
Honda
HMC
$44.2B
| $706K | 0.05% |
+26,029
| New | +$662K |
2026 Q2
0 quarters
|
|
|
225
CALL
Definium Therapeutics
DFTX
$4.6B
| $705K | 0.05% |
+15,000
| New | +$371K |
2026 Q2
0 quarters
|
|
Similar funds
FFM
AWA
SC
HCM
NB
WFA
RIM
AU
DLD Asset Management's Q2 2026 Portfolio in Review
As of Q2 2026, DLD Asset Management held 542 positions worth $1.51B, up 38% from $1.1B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
DLD Asset Management withdrew a net $406M in Q2 2026, closing 94 positions and reducing 33 holdings. Its most notable exit was Medline Inc, an estimated $9.79M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 78% of assets, up from 73% a quarter earlier, followed by Financials and Technology.
Against the trend, DLD Asset Management opened a new position in Amkor Technology worth $12.1M.
- DLD Asset Management's largest Q2 2026 buy was Amkor Technology: 140,000 shares worth $12.1M.
- DLD Asset Management added most to Norfolk Southern in Q2 2026, an estimated $4.48M increase.
- DLD Asset Management's biggest Q2 2026 reduction was D. Boral Acquisition I Corp, cutting an estimated $4.96M.
- DLD Asset Management fully exited Medline Inc in Q2 2026, selling an estimated $9.79M.
- DLD Asset Management's ten largest holdings make up 45% of its $1.51B portfolio in Q2 2026.
- DLD Asset Management opened 183 new positions and closed 94 in Q2 2026.
- DLD Asset Management's portfolio value rose 38% quarter-over-quarter to $1.51B.
Based on DLD Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.